Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

318.63
+7.512.41%
Volume:467.06K
Turnover:148.00M
Market Cap:41.55B
PE:-151.85
High:319.98
Open:311.26
Low:311.26
Close:311.12
Loading ...
Feb 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Correspondence

Form CORRESP - Correspondence
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities